nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CALM2—artery—systemic scleroderma	0.0264	0.0759	CbGeAlD
Phenoxybenzamine—CALM1—artery—systemic scleroderma	0.0262	0.0756	CbGeAlD
Phenoxybenzamine—CALM2—endothelium—systemic scleroderma	0.0223	0.0641	CbGeAlD
Phenoxybenzamine—CALM1—endothelium—systemic scleroderma	0.0222	0.0639	CbGeAlD
Phenoxybenzamine—CALM2—blood vessel—systemic scleroderma	0.0205	0.0592	CbGeAlD
Phenoxybenzamine—CALM1—blood vessel—systemic scleroderma	0.0204	0.0589	CbGeAlD
Phenoxybenzamine—SLC22A2—digestive system—systemic scleroderma	0.0133	0.0382	CbGeAlD
Phenoxybenzamine—SLC22A3—connective tissue—systemic scleroderma	0.0124	0.0357	CbGeAlD
Phenoxybenzamine—CALM3—smooth muscle tissue—systemic scleroderma	0.0123	0.0353	CbGeAlD
Phenoxybenzamine—SLC22A3—smooth muscle tissue—systemic scleroderma	0.0113	0.0327	CbGeAlD
Phenoxybenzamine—CALM2—connective tissue—systemic scleroderma	0.0105	0.0303	CbGeAlD
Phenoxybenzamine—CALM1—connective tissue—systemic scleroderma	0.0105	0.0302	CbGeAlD
Phenoxybenzamine—CALM2—smooth muscle tissue—systemic scleroderma	0.00963	0.0277	CbGeAlD
Phenoxybenzamine—CALM1—smooth muscle tissue—systemic scleroderma	0.00958	0.0276	CbGeAlD
Phenoxybenzamine—CALM2—skin of body—systemic scleroderma	0.00951	0.0274	CbGeAlD
Phenoxybenzamine—CALM1—skin of body—systemic scleroderma	0.00946	0.0273	CbGeAlD
Phenoxybenzamine—CALM3—tendon—systemic scleroderma	0.00921	0.0265	CbGeAlD
Phenoxybenzamine—CALM3—lung—systemic scleroderma	0.00809	0.0233	CbGeAlD
Phenoxybenzamine—Nasal congestion—Pentoxifylline—systemic scleroderma	0.00807	0.0751	CcSEcCtD
Phenoxybenzamine—CALM2—digestive system—systemic scleroderma	0.0076	0.0219	CbGeAlD
Phenoxybenzamine—CALM1—digestive system—systemic scleroderma	0.00757	0.0218	CbGeAlD
Phenoxybenzamine—ADRA2A—connective tissue—systemic scleroderma	0.00751	0.0216	CbGeAlD
Phenoxybenzamine—SLC22A3—lung—systemic scleroderma	0.00748	0.0215	CbGeAlD
Phenoxybenzamine—CALM2—tendon—systemic scleroderma	0.00724	0.0208	CbGeAlD
Phenoxybenzamine—CALM1—tendon—systemic scleroderma	0.0072	0.0208	CbGeAlD
Phenoxybenzamine—Nasal congestion—Mometasone—systemic scleroderma	0.00696	0.0648	CcSEcCtD
Phenoxybenzamine—ADRA2C—tendon—systemic scleroderma	0.00647	0.0186	CbGeAlD
Phenoxybenzamine—CALM2—lung—systemic scleroderma	0.00635	0.0183	CbGeAlD
Phenoxybenzamine—CALM1—lung—systemic scleroderma	0.00632	0.0182	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.00609	0.0567	CcSEcCtD
Phenoxybenzamine—ADRA2C—lung—systemic scleroderma	0.00568	0.0164	CbGeAlD
Phenoxybenzamine—Drowsiness—Pentoxifylline—systemic scleroderma	0.00566	0.0528	CcSEcCtD
Phenoxybenzamine—ADRA2A—tendon—systemic scleroderma	0.00516	0.0149	CbGeAlD
Phenoxybenzamine—Orthostatic hypotension—Captopril—systemic scleroderma	0.00509	0.0474	CcSEcCtD
Phenoxybenzamine—ADRA2A—lung—systemic scleroderma	0.00453	0.013	CbGeAlD
Phenoxybenzamine—Nasal congestion—Lisinopril—systemic scleroderma	0.00433	0.0403	CcSEcCtD
Phenoxybenzamine—CYP3A4—digestive system—systemic scleroderma	0.00427	0.0123	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Azathioprine—systemic scleroderma	0.00403	0.0375	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.004	0.0373	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.0036	0.0336	CcSEcCtD
Phenoxybenzamine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00352	0.0328	CcSEcCtD
Phenoxybenzamine—Somnolence—Pentoxifylline—systemic scleroderma	0.00321	0.0299	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00316	0.0294	CcSEcCtD
Phenoxybenzamine—Fatigue—Mometasone—systemic scleroderma	0.00269	0.025	CcSEcCtD
Phenoxybenzamine—Tachycardia—Captopril—systemic scleroderma	0.00267	0.0249	CcSEcCtD
Phenoxybenzamine—Asthenia—Pentoxifylline—systemic scleroderma	0.00259	0.0241	CcSEcCtD
Phenoxybenzamine—Somnolence—Captopril—systemic scleroderma	0.00243	0.0227	CcSEcCtD
Phenoxybenzamine—Fatigue—Captopril—systemic scleroderma	0.00236	0.022	CcSEcCtD
Phenoxybenzamine—Asthenia—Mometasone—systemic scleroderma	0.00224	0.0208	CcSEcCtD
Phenoxybenzamine—Tachycardia—Leflunomide—systemic scleroderma	0.0022	0.0205	CcSEcCtD
Phenoxybenzamine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.0021	0.0196	CcSEcCtD
Phenoxybenzamine—Asthenia—Captopril—systemic scleroderma	0.00196	0.0183	CcSEcCtD
Phenoxybenzamine—Fatigue—Leflunomide—systemic scleroderma	0.00194	0.0181	CcSEcCtD
Phenoxybenzamine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00191	0.0178	CcSEcCtD
Phenoxybenzamine—Tachycardia—Lisinopril—systemic scleroderma	0.00189	0.0176	CcSEcCtD
Phenoxybenzamine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00186	0.0173	CcSEcCtD
Phenoxybenzamine—Somnolence—Lisinopril—systemic scleroderma	0.00172	0.0161	CcSEcCtD
Phenoxybenzamine—Fatigue—Lisinopril—systemic scleroderma	0.00167	0.0156	CcSEcCtD
Phenoxybenzamine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00166	0.0154	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00162	0.0151	CcSEcCtD
Phenoxybenzamine—Asthenia—Leflunomide—systemic scleroderma	0.00162	0.0151	CcSEcCtD
Phenoxybenzamine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00154	0.0144	CcSEcCtD
Phenoxybenzamine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00151	0.0141	CcSEcCtD
Phenoxybenzamine—Drowsiness—Methotrexate—systemic scleroderma	0.00151	0.0141	CcSEcCtD
Phenoxybenzamine—Asthenia—Lisinopril—systemic scleroderma	0.00139	0.013	CcSEcCtD
Phenoxybenzamine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00122	0.0114	CcSEcCtD
Phenoxybenzamine—Tachycardia—Prednisone—systemic scleroderma	0.00112	0.0105	CcSEcCtD
Phenoxybenzamine—Fatigue—Prednisone—systemic scleroderma	0.000993	0.00925	CcSEcCtD
Phenoxybenzamine—Somnolence—Methotrexate—systemic scleroderma	0.000855	0.00797	CcSEcCtD
Phenoxybenzamine—Fatigue—Methotrexate—systemic scleroderma	0.00083	0.00773	CcSEcCtD
Phenoxybenzamine—Asthenia—Prednisone—systemic scleroderma	0.000826	0.00769	CcSEcCtD
Phenoxybenzamine—Asthenia—Methotrexate—systemic scleroderma	0.00069	0.00643	CcSEcCtD
Phenoxybenzamine—CALM2—Adaptive Immune System—BLK—systemic scleroderma	0.000593	0.00109	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—BLK—systemic scleroderma	0.000593	0.00109	CbGpPWpGaD
Phenoxybenzamine—CALM1—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000591	0.00108	CbGpPWpGaD
Phenoxybenzamine—CALM2—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000591	0.00108	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—CTGF—systemic scleroderma	0.000574	0.00105	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—SMAD7—systemic scleroderma	0.000567	0.00104	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—RHOB—systemic scleroderma	0.000563	0.00103	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—SMAD7—systemic scleroderma	0.00056	0.00103	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—EDN1—systemic scleroderma	0.00056	0.00103	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—SMAD7—systemic scleroderma	0.000559	0.00103	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR ligand binding—CCL2—systemic scleroderma	0.000559	0.00102	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—MMP1—systemic scleroderma	0.000555	0.00102	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—SMAD7—systemic scleroderma	0.000542	0.000993	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—SMAD7—systemic scleroderma	0.000542	0.000993	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	0.000541	0.000992	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—SMAD7—systemic scleroderma	0.000529	0.00097	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—SMAD7—systemic scleroderma	0.000521	0.000955	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—MMP1—systemic scleroderma	0.000518	0.00095	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000516	0.000946	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—RHOB—systemic scleroderma	0.000514	0.000942	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TGFBI—systemic scleroderma	0.000512	0.000939	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR ligand binding—CCL2—systemic scleroderma	0.000505	0.000925	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	0.000503	0.000922	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CTLA4—systemic scleroderma	0.000502	0.00092	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—CCL2—systemic scleroderma	0.000498	0.000913	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—RHOB—systemic scleroderma	0.000497	0.000911	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—RHOB—systemic scleroderma	0.000497	0.000911	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TGFBI—systemic scleroderma	0.000496	0.000908	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TGFBI—systemic scleroderma	0.000496	0.000908	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CTLA4—systemic scleroderma	0.000486	0.00089	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CTLA4—systemic scleroderma	0.000486	0.00089	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—RHOB—systemic scleroderma	0.000486	0.00089	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000482	0.000883	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—HSPG2—systemic scleroderma	0.000475	0.00087	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—CCL2—systemic scleroderma	0.000471	0.000864	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—CCL2—systemic scleroderma	0.000464	0.00085	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SMAD7—systemic scleroderma	0.000463	0.000848	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—EDN1—systemic scleroderma	0.000462	0.000847	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—HSPG2—systemic scleroderma	0.000462	0.000846	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HSPG2—systemic scleroderma	0.000458	0.000839	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—HSPG2—systemic scleroderma	0.000443	0.000811	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CSK—systemic scleroderma	0.000442	0.000811	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—RHOB—systemic scleroderma	0.000438	0.000803	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—RHOB—systemic scleroderma	0.000433	0.000793	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SMAD7—systemic scleroderma	0.00043	0.000788	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CSK—systemic scleroderma	0.000427	0.000784	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—MMP1—systemic scleroderma	0.000421	0.000772	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IRF5—systemic scleroderma	0.000421	0.000771	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—EDN1—systemic scleroderma	0.00042	0.000769	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—EDN1—systemic scleroderma	0.000417	0.000765	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000414	0.000758	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CSK—systemic scleroderma	0.000414	0.000758	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CSK—systemic scleroderma	0.000414	0.000758	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HSPG2—systemic scleroderma	0.000413	0.000758	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—CCL2—systemic scleroderma	0.000412	0.000755	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—EDN1—systemic scleroderma	0.000412	0.000755	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—RHOB—systemic scleroderma	0.000409	0.00075	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HSPG2—systemic scleroderma	0.000409	0.000749	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HSPG2—systemic scleroderma	0.000408	0.000748	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IRF5—systemic scleroderma	0.000407	0.000746	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IRF5—systemic scleroderma	0.000407	0.000746	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—RHOB—systemic scleroderma	0.000403	0.000739	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—NOS3—systemic scleroderma	0.000402	0.000737	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—ITGAM—systemic scleroderma	0.000402	0.000737	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IRF8—systemic scleroderma	0.000402	0.000737	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD247—systemic scleroderma	0.000402	0.000737	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.0004	0.000733	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.0004	0.000733	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CSK—systemic scleroderma	0.000399	0.000732	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HSPG2—systemic scleroderma	0.000395	0.000725	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HSPG2—systemic scleroderma	0.000395	0.000725	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CSK—systemic scleroderma	0.000395	0.000723	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CSK—systemic scleroderma	0.000394	0.000722	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SMAD7—systemic scleroderma	0.000392	0.000719	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000391	0.000718	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CD40LG—systemic scleroderma	0.000391	0.000716	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—EDN1—systemic scleroderma	0.00039	0.000714	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IRF8—systemic scleroderma	0.000389	0.000713	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IRF8—systemic scleroderma	0.000389	0.000713	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD247—systemic scleroderma	0.000389	0.000713	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD247—systemic scleroderma	0.000389	0.000713	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—ITGAM—systemic scleroderma	0.000389	0.000713	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—ITGAM—systemic scleroderma	0.000389	0.000713	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HSPG2—systemic scleroderma	0.000386	0.000708	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—MMP1—systemic scleroderma	0.000384	0.000704	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—EDN1—systemic scleroderma	0.000384	0.000703	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—CCL2—systemic scleroderma	0.000383	0.000702	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CSK—systemic scleroderma	0.000382	0.0007	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CSK—systemic scleroderma	0.000382	0.0007	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HSPG2—systemic scleroderma	0.00038	0.000697	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SMAD7—systemic scleroderma	0.000379	0.000696	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SMAD7—systemic scleroderma	0.000379	0.000696	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—EDN1—systemic scleroderma	0.000379	0.000694	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CD40LG—systemic scleroderma	0.000378	0.000692	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CD40LG—systemic scleroderma	0.000378	0.000692	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—TNFAIP3—systemic scleroderma	0.000376	0.00069	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—NOS3—systemic scleroderma	0.000376	0.000689	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—HSPG2—systemic scleroderma	0.000375	0.000687	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—EDN1—systemic scleroderma	0.000374	0.000686	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CSK—systemic scleroderma	0.000373	0.000684	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—BLK—systemic scleroderma	0.000372	0.000682	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—MMP1—systemic scleroderma	0.000372	0.000681	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—MMP1—systemic scleroderma	0.000372	0.000681	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CD247—systemic scleroderma	0.000371	0.00068	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CSK—systemic scleroderma	0.000367	0.000673	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—TNFAIP3—systemic scleroderma	0.000364	0.000667	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—TNFAIP3—systemic scleroderma	0.000364	0.000667	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—CTGF—systemic scleroderma	0.00036	0.000659	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—BLK—systemic scleroderma	0.00036	0.000659	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—BLK—systemic scleroderma	0.00036	0.000659	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CD247—systemic scleroderma	0.000359	0.000658	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CD247—systemic scleroderma	0.000359	0.000658	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—RHOB—systemic scleroderma	0.000358	0.000656	CbGpPWpGaD
Phenoxybenzamine—CALM3—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000357	0.000655	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—EDN1—systemic scleroderma	0.000354	0.000649	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—CTGF—systemic scleroderma	0.00035	0.000641	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—EDN1—systemic scleroderma	0.000348	0.000638	CbGpPWpGaD
Phenoxybenzamine—CALM2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000346	0.000633	CbGpPWpGaD
Phenoxybenzamine—CALM1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000346	0.000633	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—HSPG2—systemic scleroderma	0.000342	0.000627	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—EDN1—systemic scleroderma	0.000341	0.000624	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HSPG2—systemic scleroderma	0.000338	0.000619	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—CTGF—systemic scleroderma	0.000335	0.000615	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—RHOB—systemic scleroderma	0.000333	0.00061	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—HSPG2—systemic scleroderma	0.000331	0.000607	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—HSPG2—systemic scleroderma	0.000331	0.000607	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CSK—systemic scleroderma	0.000326	0.000598	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—EDN1—systemic scleroderma	0.000317	0.00058	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HSPG2—systemic scleroderma	0.000314	0.000575	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—EDN1—systemic scleroderma	0.000309	0.000567	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—NOS3—systemic scleroderma	0.000305	0.000559	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CTLA4—systemic scleroderma	0.000305	0.000558	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—RHOB—systemic scleroderma	0.000303	0.000556	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CSK—systemic scleroderma	0.000303	0.000555	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CTLA4—systemic scleroderma	0.000295	0.00054	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CTLA4—systemic scleroderma	0.000295	0.00054	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—RHOB—systemic scleroderma	0.000294	0.000538	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—RHOB—systemic scleroderma	0.000294	0.000538	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—EDN1—systemic scleroderma	0.000287	0.000527	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—CCL2—systemic scleroderma	0.000287	0.000526	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HSPG2—systemic scleroderma	0.000286	0.000525	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—CTGF—systemic scleroderma	0.000284	0.000521	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—NOS3—systemic scleroderma	0.000278	0.00051	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HSPG2—systemic scleroderma	0.000277	0.000507	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HSPG2—systemic scleroderma	0.000277	0.000507	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CSK—systemic scleroderma	0.000276	0.000507	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—NOS3—systemic scleroderma	0.000269	0.000494	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—NOS3—systemic scleroderma	0.000269	0.000494	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CSK—systemic scleroderma	0.000267	0.00049	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CSK—systemic scleroderma	0.000267	0.00049	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—TGFB1—systemic scleroderma	0.000266	0.000487	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—EDN1—systemic scleroderma	0.000262	0.000481	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—CTGF—systemic scleroderma	0.000259	0.000475	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—CCL2—systemic scleroderma	0.000259	0.000475	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—CCL2—systemic scleroderma	0.000256	0.000469	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—EDN1—systemic scleroderma	0.000254	0.000465	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—EDN1—systemic scleroderma	0.000254	0.000465	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—CTGF—systemic scleroderma	0.000251	0.00046	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—CTGF—systemic scleroderma	0.000251	0.00046	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-DQB1—systemic scleroderma	0.000251	0.00046	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—NOS3—systemic scleroderma	0.00025	0.000458	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—TGFB1—systemic scleroderma	0.000248	0.000455	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EDN1—systemic scleroderma	0.000248	0.000454	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-DQB1—systemic scleroderma	0.000243	0.000445	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-DQB1—systemic scleroderma	0.000243	0.000445	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—CCL2—systemic scleroderma	0.000242	0.000443	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL1A—systemic scleroderma	0.000238	0.000437	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—CCL2—systemic scleroderma	0.000238	0.000436	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD40LG—systemic scleroderma	0.000237	0.000434	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1A—systemic scleroderma	0.00023	0.000422	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1A—systemic scleroderma	0.00023	0.000422	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD40LG—systemic scleroderma	0.000229	0.00042	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD40LG—systemic scleroderma	0.000229	0.00042	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EDN1—systemic scleroderma	0.000224	0.00041	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EDN1—systemic scleroderma	0.000221	0.000405	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—CCL2—systemic scleroderma	0.000211	0.000388	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EDN1—systemic scleroderma	0.000209	0.000383	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EDN1—systemic scleroderma	0.000206	0.000377	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—TGFB1—systemic scleroderma	0.000202	0.00037	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—CCL2—systemic scleroderma	0.000196	0.00036	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TGFB1—systemic scleroderma	0.000184	0.000337	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EDN1—systemic scleroderma	0.000183	0.000335	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—CCL2—systemic scleroderma	0.000179	0.000329	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TGFB1—systemic scleroderma	0.000178	0.000326	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TGFB1—systemic scleroderma	0.000178	0.000326	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CCL2—systemic scleroderma	0.000173	0.000318	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CCL2—systemic scleroderma	0.000173	0.000318	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EDN1—systemic scleroderma	0.00017	0.000311	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CCL2—systemic scleroderma	0.000169	0.000311	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—HSPG2—systemic scleroderma	0.00016	0.000293	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—NOS3—systemic scleroderma	0.000157	0.000287	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EDN1—systemic scleroderma	0.000155	0.000284	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CCL2—systemic scleroderma	0.000153	0.00028	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—NOS3—systemic scleroderma	0.000152	0.000279	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NOS3—systemic scleroderma	0.000151	0.000277	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CCL2—systemic scleroderma	0.000151	0.000277	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EDN1—systemic scleroderma	0.00015	0.000275	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EDN1—systemic scleroderma	0.00015	0.000275	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—NOS3—systemic scleroderma	0.000146	0.000268	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCL2—systemic scleroderma	0.000143	0.000262	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCL2—systemic scleroderma	0.000141	0.000258	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NOS3—systemic scleroderma	0.000136	0.00025	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NOS3—systemic scleroderma	0.000135	0.000247	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NOS3—systemic scleroderma	0.000135	0.000247	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NOS3—systemic scleroderma	0.00013	0.000239	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NOS3—systemic scleroderma	0.00013	0.000239	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NOS3—systemic scleroderma	0.000127	0.000233	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NOS3—systemic scleroderma	0.000125	0.00023	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCL2—systemic scleroderma	0.000125	0.000229	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL1B—systemic scleroderma	0.000124	0.000228	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—NOS3—systemic scleroderma	0.000124	0.000227	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MMP9—systemic scleroderma	0.000121	0.000222	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CTGF—systemic scleroderma	0.000121	0.000222	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1B—systemic scleroderma	0.00012	0.00022	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1B—systemic scleroderma	0.00012	0.00022	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCL2—systemic scleroderma	0.000116	0.000213	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—NOS3—systemic scleroderma	0.000113	0.000207	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NOS3—systemic scleroderma	0.000111	0.000204	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MMP9—systemic scleroderma	0.000109	0.000201	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—NOS3—systemic scleroderma	0.000109	0.0002	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—NOS3—systemic scleroderma	0.000109	0.0002	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MMP9—systemic scleroderma	0.000108	0.000198	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCL2—systemic scleroderma	0.000106	0.000194	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NOS3—systemic scleroderma	0.000103	0.00019	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL2—systemic scleroderma	0.000102	0.000188	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL2—systemic scleroderma	0.000102	0.000188	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MMP9—systemic scleroderma	0.000102	0.000187	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MMP9—systemic scleroderma	0.000101	0.000184	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TGFB1—systemic scleroderma	9.99e-05	0.000183	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NOS3—systemic scleroderma	9.44e-05	0.000173	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NOS3—systemic scleroderma	9.13e-05	0.000167	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NOS3—systemic scleroderma	9.13e-05	0.000167	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TGFB1—systemic scleroderma	9.02e-05	0.000165	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MMP9—systemic scleroderma	8.93e-05	0.000164	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TGFB1—systemic scleroderma	8.91e-05	0.000163	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TGFB1—systemic scleroderma	8.9e-05	0.000163	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TGFB1—systemic scleroderma	8.62e-05	0.000158	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TGFB1—systemic scleroderma	8.62e-05	0.000158	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TGFB1—systemic scleroderma	8.42e-05	0.000154	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MMP9—systemic scleroderma	8.3e-05	0.000152	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TGFB1—systemic scleroderma	8.29e-05	0.000152	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MMP9—systemic scleroderma	7.57e-05	0.000139	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TGFB1—systemic scleroderma	7.36e-05	0.000135	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MMP9—systemic scleroderma	7.33e-05	0.000134	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MMP9—systemic scleroderma	7.33e-05	0.000134	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TGFB1—systemic scleroderma	6.84e-05	0.000125	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TGFB1—systemic scleroderma	6.24e-05	0.000114	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TGFB1—systemic scleroderma	6.04e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TGFB1—systemic scleroderma	6.04e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NOS3—systemic scleroderma	5.27e-05	9.66e-05	CbGpPWpGaD
